Logo UCA
Icon P.S.

Informations du chercheur

Nom complet

Belbaraka rhizlane

Grade

PES

Spécialité

oncologie

Thématique de recherche

santé

Laboratoire

Laboratoire Biosciences et santé

Établissement

Faculté de Médecine et de Pharmacie de Marrakech

Projets (0 au total)

Aucun projet disponible.

Publications (47 au total)

Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence

Auteur: Nada Benhima, Rhizlane Belbaraka, Mireille D Langouo Fontsa

Revue: Current Opinion in Oncology

Année: 2024

DOI: 10.1097/CCO.0000000000001014.

Building a United Front: Radiation Oncologists as Collaborative Partners, Not Competitors, to Medical Oncologists

Auteur: Nada Benhima, Khalid El Bairi, Mohammed El Fadli, Rhizlane Belbaraka

Revue: JCO Global Oncology

Année: 2024

DOI: 10.1200/go.24.00191

Factors linked to the late diagnosis of breast cancer and the initiation of treatment

Auteur: Ganiou Adjadé, Kalil Cissé, Mohammed El Fadli, Ismail Essadi, Rhizlane Belbaraka

Revue: The Pan African Medical Journal

Année: 2024

DOI: 10.11604/pamj.2024.47.207.42734

Therapeutic Strategy for Functional Metastatic Malignant Paraganglioma: A Case Report and Review of the Literature

Auteur: Yousra Bennouna, Nadin Shawar Al Tamimi, Ganiou Adjade, Mohamed El Fadli, Ismail Essadi, Rhizlane Belbaraka

Revue: Cureus

Année: 2024

DOI: 10.7759/cureus.60027

The Use of Granulocyte Colony-Stimulating Factor as Primary Prophylaxis in Patients Undergoing Chemotherapy: An Experience of Moroccan Oncologists

Auteur: Mohamed Kaakoua, Soukayna Boujmadi, Rhizlane Belbaraka, Ismail Essadi

Revue: Cureus

Année: 2024

DOI: 10.7759/cureus.54482

Pazopanib-induced trismus in a young male with metastatic renal cell carcinoma: a case report and literature review

Auteur: Nada Benhima, Mohammed El Fadli, Ismail Essâdi, Rhizlane Belbaraka

Revue: Oxford Medical Case Reports

Année: 2024

DOI: 10.1093/omcr/omad146

Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study

Auteur: Farah Choulli, Hassan Abdelilah Tafenzi, Faiçal EL Hattimy, Mohamed Khaled Choulli, Rhizlane Belbaraka

Revue: BMC Cancer

Année: 2024

DOI: 10.1186/s12885-023-11616-5

Real world results of locally advanced and metastatic lung cancer patients treated with platinum doublet chemotherapy in first line: Moroccan cohort

Auteur: Hassan Abdelilah Tafenzi, Farah Choulli, Edwin Kelly Haag, Anass Baladi, Ismail Essaadi, Rhizlane Belbaraka

Revue: Translational Oncology

Année: 2024

DOI: 10.1016/j.tranon.2024.102015

Advancing inclusive research (AIR) in Africa: Strengthening healthcare systems to enhance access on the continent through the Africa AIR site alliance model.

Auteur: Atara Isaiah Ntekim, Rhizlane Belbaraka, Tumelo Moyaba, Primus Ochieng, Huwaida Bulhan, Terver Akindigh, Nathaniel Ramuthaga, Matodzi Nelmawondo, Hanae Ibn El Haj, Catherine Ofori-Atta, Angela Kiraba, Micheal Johnstone, Nicole Richie, Ruma Bhagat

Revue: Journal of Clinical Oncology

Année: 2024

DOI: 10.1200/jco.2024.42.16_suppl.e13778

Communications (25 au total)

Cancer de la prostate: place du Zoladex à l'ère des nouvelles thérapies

Manifestation: 31ème Congrès National d'Urologie

Date: 2024-05-11

Organisation: Marrakech

Interventional Oncology Trials in Africa Then, Now and Next

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-05

Organisation: DAKAR, SENEGAL

Breast Cancer: Improving the Patient Journey in Morocco

Manifestation: AORTIC 2023: Cancer in Africa: Implementation, Workforce, Opportunities

Date: 2023-11-04

Organisation: DAKAR, Senegal

Risk factors, and prognostic factors, for progression free survival in patients with newly diagnosed of lung cancer: a population-based study

Manifestation: Congrès de l' Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

Controversies in Lung Cancer: which second line after platinum based chemotherapy?

Manifestation: Congrès de l'Association Marocaine de Formation et Recherche en Oncologie Médicale

Date: 2023-10-06

Organisation: Tanger

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy (Hna Maak).

Manifestation: 6ème édition Forum Galien

Date: 2023-10-03

Organisation: Dakar- Senegal

Development and validation of a predictive tool for oesophageal cancer patients: A Moroccan-based study.

Manifestation: 25th World Congress on Gastrointestinal Cancer

Date: 2023-06-29

Organisation: Barcelone- Espagne

Nouveautés dans le cancer du sein triple négatif et Her 2 low

Manifestation: 1st Maghreb Summit Astra Zeneca

Date: 2023-02-25

Organisation: Tunis, Tunisie

An AI mobile health app for remote support and monitoring of breast cancer patients undergoing chemotherapy.

Manifestation: 2ème édition du congrès Healthcare et Innovation

Date: 2023-02-23

Organisation: Casablanca